Cambrex

Highly Engaged Employees

Cambrex, founded in 1981, is a leading global contract development and manufacturing organization (CDMO) providing comprehensive drug substance, drug product, and analytical services throughout the drug lifecycle. With over 40 years of experience, Cambrex supports global clients across North America and Europe in both branded and generic markets for API and finished dosage form development and manufacturing. The company is a trusted partner, leveraging its expertise to facilitate the efficient and reliable delivery of new therapies. Its commitment to quality and innovation underpins its operations, ensuring robust solutions for complex pharmaceutical challenges from early-stage development to commercialization.

The organization offers a wide array of specialized drug substance technologies, including continuous flow processing, controlled substance handling, advanced solid-state science, material characterization, stability storage, and the manufacturing of highly potent APIs. Cambrex also supports conventional dosage forms like oral solids, semi-solids, and liquids, alongside specialty forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, sterile, and non-sterile ointments. Operating with a team of 1,000-5,000 employees across 16 locations, Cambrex provides extensive capabilities. Meet Cambrex's team to learn more about their dedicated professionals.

With an annual revenue of $717.6 million, Cambrex competes in a dynamic pharmaceutical landscape, serving clients ranging from emerging biotechs to large pharmaceutical corporations. Its comprehensive service offering positions it as a key player, enabling the commercialization of diverse therapeutic agents. The company's strategic focus on advanced manufacturing technologies and a broad spectrum of dosage forms allows it to address a wide range of client needs, from early-stage developmentView more...